These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36582051)

  • 1. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation.
    Lauritzen F; Holden G
    Drug Test Anal; 2023 May; 15(5):506-515. PubMed ID: 36582051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.
    Terreros JL; Manonelles P; López-Plaza D
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Anti-Doping Rule Violations That Have Impacted Medal Results at the Summer Olympic Games 1968-2012.
    Kolliari-Turner A; Lima G; Hamilton B; Pitsiladis Y; Guppy FM
    Sports Med; 2021 Oct; 51(10):2221-2229. PubMed ID: 33835351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping in the Ultimate Fighting Championship (UFC): A 4-year epidemiological analysis.
    Fares MY; Baydoun H; Salhab HA; Khachfe HH; Fares Y; Fares J; Abboud JA
    Drug Test Anal; 2021 Apr; 13(4):785-793. PubMed ID: 33270353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM; Fließer M
    Subst Abuse Treat Prev Policy; 2016 Oct; 11(1):35. PubMed ID: 27724975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can We Better Integrate the Role of Anti-Doping in Sports and Society? A Psychological Approach to Contemporary Value-Based Prevention.
    Petróczi A; Norman P; Brueckner S
    Med Sport Sci; 2017; 62():160-176. PubMed ID: 28571017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of new anti-doping measures on sports performance in elite female athletes.
    Bezuglov E; Talibov O; Lazarev A; Waśkiewicz Z; Iljukov S
    Drug Test Anal; 2023 Aug; 15(8):889-895. PubMed ID: 37069126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping in Paralympic sport: perceptions, responsibility and anti-doping education experiences from the perspective of Paralympic athletes and parasport coaches.
    Blank C; Weber K; Boardley ID; Abel T; Schobersberger W; Patterson LB
    Front Sports Act Living; 2023; 5():1166139. PubMed ID: 37483282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The purpose and effectiveness of doping testing in sport.
    Lauritzen F; Solheim A
    Front Sports Act Living; 2024; 6():1386539. PubMed ID: 38803418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive performance as a discriminator of doping status in elite athletes.
    Hopker JG; Griffin JE; Hinoveanu LC; Saugy J; Faiss R
    Drug Test Anal; 2024 May; 16(5):473-481. PubMed ID: 37602904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The team effect on doping in professional male road cycling (2005-2016).
    Aubel O; Lefèvre B; Le Goff JM; Taverna N
    Scand J Med Sci Sports; 2019 Apr; 29(4):615-622. PubMed ID: 30636331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.